Moneycontrol PRO
Loans
Loans
HomeNewsGlobal health

Global Health

Jump to
  • Stocks to Watch Today: Wipro, Whirlpool, Sudeep Pharma, Ashoka Buildcon, Zydus Life, Tata Tech, Refex Industries, Bandhan Bank in focus on 28 November

    Stocks to Watch, 28 November: Stocks like Wipro, Ashoka Buildcon, Zydus Lifesciences, Tata Technologies, Refex Industries, Emcure Pharmaceuticals, Global Health, Excelsoft Technologies, Lemon Tree Hotels, Bandhan Bank, CarTrade Tech, Whirlpool of India, Saregama India, and Sudeep Pharma will be in focus on November 28.

  • Buy Global Health; target of Rs 1480: Motilal Oswal

    Motilal Oswal is bullish on Global Health recommended buy rating on the stock with a target price of Rs 1480 in its research report dated November 26, 2025.

  • Trade Spotlight: How should you trade Apex Frozen, Hero MotoCorp, Tata Communications, Mahindra Finance, Global Health, and others on November 24?

    The market is expected to be rangebound until it trades below the previous week’s high. Below are some short-term trading ideas to consider.

  • Buy Global Health; target of Rs 1480: Motilal Oswal

    Motilal Oswal is bullish on Global Health has recommended buy rating on the stock with a target price of Rs 1480 in its research report dated November 10, 2025.

  • Global Health Standalone September 2025 Net Sales at Rs 926.43 crore, up 39.4% Y-o-Y

  • Global Health Consolidated September 2025 Net Sales at Rs 1,099.22 crore, up 14.91% Y-o-Y

  • Global Health Consolidated September 2025 Net Sales at Rs 1,099.22 crore, up 14.91% Y-o-Y

  • Stocks to Watch Today: Lenskart, Cyient, Havells, Lupin, Swiggy, Hindustan Aeronautics, Ashoka Buildcon, Biocon, Nykaa, Kalyan Jewellers in focus on 10 November

    Stocks to Watch, 10 November: Stocks like Bajaj Auto, FSN E-Commerce Ventures Nykaa, Kalyan Jewellers India, JSW Cement,Trent, Global Health, Neuland Laboratories, Ratnamani Metals and Tubes, National Aluminium Company, Force Motors, Torrent Pharmaceuticals, VA Tech Wabag, Olectra Greentech, and Lenskart Solutions will be in focus on November 10.

  • Global Health Standalone June 2025 Net Sales at Rs 882.16 crore, up 44.27% Y-o-Y

  • Global Health Consolidated June 2025 Net Sales at Rs 1,030.84 crore, up 19.71% Y-o-Y

  • Buy Global Health; target of Rs 1630: Motilal Oswal

    Motilal Oswal is bullish on Global Health has recommended buy rating on the stock with a target price of Rs 1630 in its research report dated August 10, 2025.

  • Trade Spotlight: How should you trade Sanghvi Movers, Kajaria Ceramics, TVS Motor, Tech Mahindra, Medanta, Pidilite Industries, and others on August 11?

    The market may attempt a bounce back after six weeks of consistent losses, but sustainability will be the key to watch. Below are some short-term trading ideas to consider.

  • Chartist Talk: Nifty’s technical setup signals caution, but outlook bullish on these 4 stocks for next week, says Sudeep Shah of SBI Securities

    Chart formation signals a lack of conviction among bulls and a clear dominance of bears at higher levels, said Sudeep Shah of SBI Securities.

  • Stocks to Watch Today: Titan, Bharti Airtel, Biocon, Cummins, BSE, LIC, KRBL, Metropolis, Kalpataru Projects, Godrej Consumer, Kalyan Jewellers, AU SFB in focus on 8 August

    Stocks to Watch, 8 August: Stocks like Titan Company, Bharti Airtel, Biocon, Cummins India, BSE, Life Insurance Corporation, KRBL, Metropolis Healthcare, Kalpataru Projects International, Godrej Consumer Products, Kalyan Jewellers, and CE Info Systems will be in focus on August 8.

  • Optimism low on this healthcare stock

    Medanta has strong capabilities to leverage its brand image. However, near-term growth looks limited

  • Reduce Global Health; target of Rs 1175: Emkay Global Financial

    Emkay Global Financial recommended reduce rating on Global Health with a target price of Rs 1175 in its research report dated May 17, 2025.

  • Global Health Consolidated March 2025 Net Sales at Rs 931.25 crore, up 15.16% Y-o-Y

  • Global Health Standalone March 2025 Net Sales at Rs 802.87 crore, up 38.75% Y-o-Y

  • Medanta to invest Rs 500 cr to set up 400-bed hospital in Guwahati

    The company's board, in its meeting held on Monday, has approved the purchase of 3 acres of land from Assam Electricity Grid Corporation Ltd for Rs 30 crore plus incidental expenses for registration and possession of the land, the healthcare provider said in a regulatory filing.

  • Trade Spotlight: How should you trade Global Health, NTPC, Radico Khaitan, Jindal Steel, CG Power, NMDC, and others on March 7?

    The market may see some consolidation before gaining further strength toward the 20-day EMA. Below are some trading ideas for the near term.

  • Jefferies sees hospital stocks as pockets of strong earnings visibility in uncertain market

    Jefferies prefers hospital players that have higher brownfield bed expansion plans lined up for the coming years. Max Healthcare remains its top sectoral pick.

  • US actions have serious impact on global health, says WHO chief

    "There are actions that the US government is taking… which we're concerned are having a serious impact on global health," said Tedros in a virtual press conference from Geneva.

  • Reduce Global Health; target of Rs 1050: Emkay Global Financial

    Emkay Global Financial recommended reduce rating on Global Health with a target price of Rs 1050 in its research report dated February 05, 2025.

  • Trade Spotlight: How should you trade Hero MotoCorp, Muthoot Finance, Global Health, Max Healthcare, Crompton Greaves, and others on February 6?

    Overall, the sentiment remains in favour of bulls despite Wednesday's consolidation. Below are some trading ideas for the near term.

  • Global Health Standalone December 2024 Net Sales at Rs 624.40 crore, up 11.17% Y-o-Y

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347